PGA Tour will ‘name and shame’ drug users
The holiday’s over for any drug takers who may be running the gauntlet on the US Tour…starting from the new season in just a couple of months’ time.
From then on any players caught under the US PGA Tour’s Anti-Doping Program will be ‘named and shamed’.
Jay Monahan (Credit: PGA Tour)
The world’s biggest tour recently revealed it had revised their policy to include the implementation of blood testing, supplementation of Tour’s Prohibited List to include all of the substances and methods currently on the World Anti-Doping Agency (WADA) Prohibited List of Substances and Methods, and the reporting of suspensions related to drugs of abuse (recreational drugs).
The Tour will begin a comprehensive education program to ensure that all players understand the changes to the testing procedures, the Prohibited List and the adjudication process in advance of the 2017-18 season.
Blood testing will be added to the Anti-Doping Program as one of the TOUR’s regular testing protocols, beginning next season although urine testing will continue to be the predominant method.
While the vast majority of the substances on the Prohibited List are best detected through urine testing, there are some, like Human Growth Hormone, that are only detectable through blood.
To date, the PGA TOUR has not implemented blood testing, although those substances have been prohibited.
The scientific community has made substantial advancements with the creation of new detection methods, which have been successfully implemented throughout the world of sport.
In addition, golfers who competed in the Olympic Games underwent blood testing with no issues.
“While we are extremely pleased with the implementation and results of the PGA TOUR Anti-Doping Program to date, we believe that these changes to our program are prudent in that they further our objectives of protecting the well-being of our members and better substantiate the integrity of golf as a clean sport,” said PGA TOUR Commissioner Jay Monahan.